We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CHANGES TO HATCH-WAXMAN REFORMS BECOMING EVIDENT
CHANGES TO HATCH-WAXMAN REFORMS BECOMING EVIDENT
April 30, 2004
Since new drug patent rules went into effect last year, the FDA has not received a single polymorph patent for filing in the Orange Book, according to agency officials, who are seeking input on implementing the changes to the Hatch-Waxman Act patent law.